Thermo Fisher Acquires Intrinsic Bioprobes
ROCHESTER, N.Y., Sept. 2, 2011 — Thermo Fisher Scientific Inc. announced the acquisition of Intrinsic Bioprobes Inc. to enhance its work flow for biomarker research and diagnostics.
Intrinsic Bioprobes’ portfolio, including its novel mass spectrometric immunoassay (MSIA), will enable Thermo Fisher to offer its life sciences research and clinical diagnostics customers an enhanced solution for quantitative protein biomarker detection.
Intrinsic Bioprobes, headquartered in Tempe, Ariz., manufactures immuno-enrichment, sample-preparation tools used in quantitative mass spectrometry.
For more information, visit: www.thermofisher.com
- mass spectrometry
- An instrumental technique that utilizes the mass-to-charge ratio of charged particles as recorded from a mass spectrometer in order to determine the mass of a particle as well as the chemical makeup, or elemental ionic composition of a given sample or molecule.
MORE FROM PHOTONICS MEDIA